全文获取类型
收费全文 | 183564篇 |
免费 | 1298篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 1173篇 |
儿科学 | 6753篇 |
妇产科学 | 3064篇 |
基础医学 | 17648篇 |
口腔科学 | 1730篇 |
临床医学 | 12840篇 |
内科学 | 33034篇 |
皮肤病学 | 720篇 |
神经病学 | 17156篇 |
特种医学 | 9148篇 |
外科学 | 30196篇 |
综合类 | 2342篇 |
预防医学 | 18214篇 |
眼科学 | 2856篇 |
药学 | 10142篇 |
中国医学 | 665篇 |
肿瘤学 | 17265篇 |
出版年
2023年 | 44篇 |
2022年 | 98篇 |
2021年 | 229篇 |
2020年 | 88篇 |
2019年 | 135篇 |
2018年 | 22052篇 |
2017年 | 17467篇 |
2016年 | 19648篇 |
2015年 | 1078篇 |
2014年 | 997篇 |
2013年 | 1056篇 |
2012年 | 7365篇 |
2011年 | 21452篇 |
2010年 | 19104篇 |
2009年 | 11714篇 |
2008年 | 19906篇 |
2007年 | 22140篇 |
2006年 | 1038篇 |
2005年 | 2605篇 |
2004年 | 3787篇 |
2003年 | 4732篇 |
2002年 | 2912篇 |
2001年 | 454篇 |
2000年 | 590篇 |
1999年 | 360篇 |
1998年 | 334篇 |
1997年 | 314篇 |
1996年 | 197篇 |
1995年 | 186篇 |
1994年 | 197篇 |
1993年 | 140篇 |
1992年 | 172篇 |
1991年 | 232篇 |
1990年 | 236篇 |
1989年 | 198篇 |
1988年 | 178篇 |
1987年 | 137篇 |
1986年 | 125篇 |
1985年 | 143篇 |
1984年 | 90篇 |
1983年 | 84篇 |
1982年 | 62篇 |
1980年 | 82篇 |
1979年 | 47篇 |
1978年 | 44篇 |
1970年 | 39篇 |
1969年 | 46篇 |
1938年 | 60篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
961.
Shigeyuki Ebara Mikio Marumo Jun Mukai Makoto Ohki Kagehiro Uchida Ichiro Wakabayashi 《Journal of thrombosis and thrombolysis》2018,45(2):200-205
Although oxidization of LDL is known to be a crucial step for atherosclerotic progression, the significance of oxidized HDL remains to be clarified. The purpose of this study was to determine the relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with diabetes. The subjects were outpatients with type 2 diabetes (n?=?163; median hemoglobin A1c, 6.9%). Activities of blood coagulation and fibrinolysis were evaluated by levels of thrombin–anti-thrombin complex (TAT) and plasmin–α2 plasmin inhibitor complex (PIC), respectively. Relationships of oxidized HDL with TAT and PIC were investigated by using linear regression analysis and logistic regression analysis. Oxidized HDL showed a significant inverse correlation with TAT and a marginally significant correlation with PIC (Spearman’s rank correlation coefficient: TAT, ??0.205 [p?<?0.01]; PIC, ??0.135 [p?=?0.087]). Prevalence of high TAT was significantly lower in the 3rd tertile group for oxidized HDL than in its 1st tertile (20.4 vs. 5.6%, p?<?0.05), and prevalence of high PIC was marginally significantly lower in the 3rd tertile group for oxidized HDL than in its 1st tertile (40.7 vs. 24.1%, p?=?0.099). In multivariate logistic regression analysis using age, gender, smoking, alcohol drinking, BMI, hemoglobin A1c, therapy for dyslipidemia, therapy for diabetes and anti-coagulation therapy as explanatory variables, odds ratios for high TAT and high PIC in the 3rd tertile group for oxidized HDL versus its 1st tertile group were significantly lower than the reference level of 1.00 (high TAT: 0.19 [0.04–0.99], p?<?0.05; high PIC: 0.33 [0.12–0.95], p?<?0.05). The frequency of high TAT or high PIC was lower in the higher tertile group for oxidized HDL than in its lower tertile group. Thus, oxidized HDL is thought to be inversely associated with both blood coagulation and fibrinolysis in patients with type 2 diabetes. 相似文献
962.
Takanari Kitazono Yasuo Ikeda Masakatsu Nishikawa Satoshi Yoshiba Kenji Abe Akira Ogawa 《Journal of thrombosis and thrombolysis》2018,46(4):488-495
This randomized double-blind crossover study aimed to investigate the influence of cytochrome P450 (CYP) 2C19 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke treated with clopidogrel. Patients received clopidogrel 75 mg/day for >?4 weeks. Subsequently, patients received prasugrel 3.75 mg/day (group A; n?=?64) or 2.5 mg/day (group B; n?=?65) for 4 weeks followed by a 4 week switched-dose regimen. To assess the influence of CYP2C19 polymorphisms, patients were classified as extensive metabolizers (EMs), intermediate metabolizers (IMs), and poor metabolizers (PMs). The primary endpoint was P2Y12 reaction units (PRU) at the end of each 4 week treatment. A significant reduction in PRU was noted after treatment with prasugrel 3.75 mg/day compared with the pre-dose value (after treatment with clopidogrel) (p?<?0.0001). By CYP2C19 phenotypes, a significant reduction in PRU was noted in IMs and PMs after treatment with prasugrel 3.75 mg/day and in PMs after treatment with prasugrel 2.5 mg/day, as compared with the pre-dose value (p?<?0.0001). The plasma concentration of the active metabolite of clopidogrel was relatively low in PMs compared to EMs and IMs; prasugrel was similar across all CYP2C19 phenotypes. No major or clinically significant hemorrhagic adverse events occurred. By CYP2C19 phenotype, the antiplatelet effects of prasugrel were greater with 3.75 mg/day in IMs and PMs, and with 2.5 mg/day in PMs compared with clopidogrel 75 mg/day, without safety concerns. CYP2C19 polymorphisms did not affect the plasma concentration of the active metabolite of prasugrel or its antiplatelet effects. (JapicCTI-101044). 相似文献
963.
Purpose of Review
Human pluripotent stem cell-derived endothelial cells (hPSC-ECs) emerged as an important source of cells for cardiovascular regeneration. This review summarizes protocols for generating hPSC-ECs and provides an overview of the current state of the research in clinical application of hPSC-derived ECs.Recent Findings
Various systems were developed for differentiating hPSCs into the EC lineage. Stepwise two-dimensional systems are now well established, in which various growth factors, small molecules, and coating materials are used at specific developmental stages. Moreover, studies made significant advances in clinical applicability of hPSC-ECs by removing undefined components from the differentiation system, improving the differentiation efficiency, and proving their direct vascular incorporating effects, which contrast with adult stem cells and their therapeutic effects in vivo. Finally, by using biomaterial-mediated delivery, investigators improved the survival of hPSC-ECs to more than 10 months in ischemic tissues and described long-term behavior and safety of in vivo transplanted hPSC-ECs at the histological level.Summary
hPSC-derived ECs can be as a critical source of cells for treating advanced cardiovascular diseases. Over the past two decades, substantial improvement has been made in the differentiation systems and their clinical compatibility. In the near future, establishment of fully defined differentiation systems and proof of the advantages of biomaterial-mediated cell delivery, with some additional pre-clinical studies, will move this therapy into a vital option for treating those diseases that cannot be managed by currently available therapies.964.
Atul Deodhar Manish Mittal Patrick Reilly Yanjun Bao Shivaji Manthena Jaclyn Anderson Avani Joshi 《Clinical rheumatology》2016,35(7):1769-1776
This study aimed to identify providers involved in diagnosing ankylosing spondylitis (AS) following back pain diagnosis in the USA and to identify factors leading to the delay in rheumatology referrals. The Truven Health MarketScan® US Commercial Database was searched for patients aged 18–64 years with back pain diagnosis in a non-rheumatology setting followed by AS diagnosis in any setting during January 2000–December 2012. Patients with a rheumatologist visit on or before AS diagnosis were considered referred. Cox regression was used to determine factors associated with referral time after adjusting for age, sex, comorbidities, physician specialty, drug therapy, and imaging procedures. Of 3336 patients included, 1244 (37 %) were referred to and diagnosed by rheumatologists; the others were diagnosed in primary care (25.7 %), chiropractic/physical therapy (7 %), orthopedic surgery (3.8 %), pain clinic (3.6 %), acute care (3.4 %), and other (19.2 %) settings. Median time from back pain diagnosis to rheumatology referral was 307 days and from first rheumatologist visit to AS diagnosis was 28 days. Referred patients were more likely to be younger (hazard ratio [HR]?=?0.986; p?<?0.0001), male (HR?=?1.15; p?=?0.0163), diagnosed with uveitis (HR?=?1.49; p?=?0.0050), referred by primary care physicians (HR?=?1.96; p?<?0.0001), prescribed non-steroidal anti-inflammatory drugs (HR?=?1.55; p?<?0.0001), disease-modifying antirheumatic drugs (HR?=?1.33; p?<?0.0001), and tumor necrosis factor inhibitors (HR?=?1.40; p?=?0.0036), and to have had spinal/pelvic X-ray prior to referral (HR?=?1.28; p?=?0.0003). During 2000–2012, most patients with AS were diagnosed outside of rheumatology practices. The delay before referral to rheumatology was 10 months; AS diagnosis generally followed within a month. Earlier referral of patients with AS signs and symptoms may lead to more timely diagnosis and appropriate treatment. 相似文献
965.
Nathan Georgette Mark J. Siedner Brian Zanoni Thobekile Sibaya Carter R. Petty Stephen Carpenter Jessica E. Haberer 《AIDS and behavior》2016,20(11):2629-2638
Short message service (SMS) text messages have been used to remind and encourage patients to take ART in research studies. However, few studies have assessed the feasibility and acceptability of SMS in routine clinical practice. We report patient perspectives on a weekly SMS adherence support program after implementation into clinical care at an HIV clinic in KwaZulu-Natal, South Africa. We conducted structured interviews with a cross-sectional convenience sample of 100 adult patients who were invited to join the program, 88 of whom had received a program SMS. Of these respondents, 81 (92 %) would recommend the program to a friend. Sixty-eight (77 %) felt the program helped them remember clinic appointments, a response associated with male gender [odds ratio (OR) 5.88, 95 % confidence interval (CI) 1.52–23.26, P = 0.011] and HIV disclosure outside the home [OR 3.40, 95 %CI 1.00–11.60, P = 0.050]. This clinical SMS adherence program was found to have high patient-perceived usefulness. 相似文献
966.
967.
Opinion statement Left ventricular (LV) remodeling refers to alterations in ventricular mass, chamber size, and shape that result from myocardial
injury, pressure, or volume overload. Numerous studies have demonstrated that LV remodeling correlates with the incidence
of heart failure and death, supporting a causative role for remodeling in heart failure progression. Heart failure trials
have shown that neurohormonal antagonists, including angiotensin-converting enzyme (ACE) inhibitors and β-adrenergic receptor
blockers (β blockers), reduce remodeling in parallel with improved clinical outcomes. Existing data favor using angiotensin
II type 1 (AT1) receptor antagonists (or “ARBs”), although their anti-remodeling effects are less well established. Recently,
mineralocorticoid receptor antagonists have gained substantial interest based on favorable clinical trial results, although
data regarding their effects on remodeling are limited. Thus, an optimal medical regimen to prevent or limit LV remodeling
in patients with LV dysfunction should include both an ACE inhibitor and β-adrenergic receptor antagonist, irrespective of
the degree of LV dysfunction and symptom status. For patients intolerant to ACE inhibitors, an AT1 receptor antagonist should
be substituted. An aldosterone antagonist should be administered to patients with severe, New York Heart Association class
III to IV heart failure who have normal or only mildly impaired renal function, or to those patients with depressed LV function
following an acute myocardial infarction. Through the aggressive pharmacologic inhibition of both the renin-angiotensin-aldosterone
and sympathetic nervous systems, progressive LV remodeling can be prevented or hindered, thereby favorably altering the natural
history of the heart failure syndrome. 相似文献
968.
969.
Nishiura R Kita T Yamada K Komatsu H Hara S Sato Y Fujimoto S 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2008,12(2):157-163
Cardiovascular accidents related to atherosclerosis are the leading cause of death among hemodialysis patients, which makes continuous monitoring of their cardiovascular status crucial. Recently, a handy device for monitoring the augmentation index (AIx) in the radial artery was introduced in Japan, enabling the use of the AIx in addition to pulse wave velocity (PWV) in the management of hemodialysis patients. In this study the AIx, PWV, abdominal aortic calcification index (ACI), and left ventricular mass index (LVMI) were serially assessed in 108 hemodialysis patients. The radial AIx was monitored using a newly introduced tonometer (HEM-9010AI), and the interrelationships among the measured parameters and their contributions to the risk of cardiovascular accidents were evaluated. The radial AIx was significantly higher in hemodialysis patients than in healthy subjects (N = 50) and was well correlated with risk markers such as LVMI (r = 0.30, P = 0.019) and ACI (r = 0.38, P < 0.001), but not with PWV. Multiregression analysis showed that radial AIx was also significantly associated with LVMI, ACI and blood pressure; PWV was associated with other parameters such as age, blood pressure, and ACI. The AIx and ACI were both significantly increased in patients with cardiovascular complications. Although PWV was strongly increased in the hemodialysis patients, it failed to discriminate between these subgroups of high-risk patients. The radial AIx is closely associated with aortic calcification, cardiac hypertrophy, and a history of cardiovascular accidents in hemodialysis patients, and could be a useful marker for management of these patients. 相似文献
970.
Akihiko Oshita Toshiyuki Itamoto Hironobu Amano Hideki Ohdan Hirotaka Tashiro Toshimasa Asahara 《Journal of hepato-biliary-pancreatic sciences》2008,15(2):200-203
Glycogen storage disease type Ia (GSD-Ia; von Gierke disease) is an inherited disorder caused by glucose-6-phosphatase deficiency, and there have been some reports of hepatic tumors in patients with this disease. We report two patients with benign hepatic tumors with GSD-Ia. One is a 19-year-old man who underwent segmentectomy 4 for a focal nodular hyperplasia, and the other is a 31-year-old woman who underwent segmentectomies 3, 5, and 6 for hepatic adenomas. Two significant perioperative complications, resulting from the carbohydrate metabolic disorders, hypoglycemia and metabolic acidosis, occurred in both patients. We managed the metabolic complications successfully by administering a sufficient volume of glucose intravenously. Close perioperative monitoring of blood glucose and lactate concentrations is essential in the perioperative management of patients with GSD-Ia. The intravenous administration of glucose, starting with a smaller dose and then increasing the dose, is adequate management for lactic acidosis with or without hypoglycemia during the perioperative period. 相似文献